
Monro Bio
门罗生物
Monro Bio
Biotech/Healthcare
Founded in 2016 and located at the Singularity Center in Changping District, Beijing, Beijing Monroe Biotechnology Co., Ltd. is a biotech company focused on developing next-generation cell therapy drugs, dedicated to the treatment of hematologic malignancies, solid tumors, and autoimmune diseases.
Latest round: Series A (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.